PHOENIX BIOTECH ACQUISITION's ticker is and the CUSIP is 71902K105. A total of 18 filers reported holding PHOENIX BIOTECH ACQUISITION in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,240,065 | +2.0% | 217,482 | 0.0% | 0.17% | +18.4% |
| Q3 2022 | $2,197,000 | +0.7% | 217,482 | 0.0% | 0.15% | -24.2% |
| Q2 2022 | $2,181,000 | +0.2% | 217,482 | 0.0% | 0.19% | -30.7% |
| Q1 2022 | $2,176,000 | +1.0% | 217,482 | 0.0% | 0.28% | -7.9% |
| Q4 2021 | $2,155,000 | – | 217,482 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atalaya Capital Management LP | 450,000 | $4,514,000 | 0.53% |
| Lynwood Capital Management Inc. | 34,615 | $347,000 | 0.39% |
| Sage Rock Capital Management LP | 183,998 | $1,844,000 | 0.36% |
| HGC Investment Management Inc. | 1,000,000 | $10,013,000 | 0.31% |
| MMCAP International Inc. SPC | 370,000 | $3,707,000 | 0.30% |
| Context Capital Management, LLC | 400,000 | $4,008,000 | 0.29% |
| Bulldog Investors, LLP | 99,064 | $993,000 | 0.27% |
| First Trust Capital Management L.P. | 352,600 | $3,533,000 | 0.25% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,029,262 | $10,323,000 | 0.24% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 217,482 | $2,181,000 | 0.19% |